Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |